A computational prospective on isoform-selective CB2 inhibitors

被引:0
|
作者
Zhao, Yi [1 ]
Wang, Ying [2 ]
Wang, Huibin [1 ]
Hu, Baichun [3 ,4 ]
Luo, Zhaohu [2 ]
Zhang, Fengjiao [2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Shenyang 110016, Peoples R China
[3] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China
[4] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang 110016, Peoples R China
关键词
CB1R INVERSE AGONIST; CANNABINOID RECEPTOR; OVERWEIGHT PATIENTS; MOLECULAR-DYNAMICS; ACCURATE DOCKING; DISCOVERY; POTENT; GLIDE; ANTAGONIST; TARANABANT;
D O I
10.1039/d1nj02296b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cannabinoid (CB) receptors play a vital role in many pathophysiological processes. Selective CB2 activation may lead to the immuno-modulatory effects of cannabinoids being experienced without the psychoactive effects of CB1 activation; however, despite intense efforts, selective and potent CB2 agonists still remain to be developed likely due to the challenges associated with their unexpected CB1 affinity. The aim of this study was therefore to illuminate the selective mechanisms of CB1 and CB2 receptors via analyzing their interaction modes with highly selective ligands. It was found that although CB1 and CB2 exhibit high sequence homology, especially at ligand binding regions, the binding pocket of CB1 is a narrow cross shaped slit that is enclosed by several hydrophobic residues, whereas the binding pocket of CB2 is large and round and therefore would allow for more flexible ligands. In fact, hydrophobic interactions mainly account for the receptor-ligand interactions of both CB1 and CB2, with the key residues that determine the receptor selectivity being MET103, PHE170, VAL196, and PHE268 for CB1, and PHE87, PHE183, PHE94, and TRP194 for CB2. Therefore, the strategy of enlarging the molecular size, increasing hydrogen bond interactions with the key residues of CB2, and furthering the geometric distribution of hydrophobic groups would improve the selectivity towards the CB2 receptor. Collectively, these data shed promising light on elucidating the selective mechanisms between CB1 and CB2, which would lay a solid foundation for the future design of selective inhibitors towards CB2.
引用
收藏
页码:12688 / 12699
页数:12
相关论文
共 50 条
  • [41] Synthesis and characterization of novel isoform-selective IP6K1 inhibitors
    Wormald, Michael M.
    Ernst, Glen
    Wei, Huijun
    Barrow, James C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (19)
  • [42] Development of an ELISA-Based HDAC Activity Assay for Characterization of Isoform-Selective Inhibitors
    Padige, Geetha
    Negmeldin, Ahmed T.
    Pflum, Mary Kay H.
    JOURNAL OF BIOMOLECULAR SCREENING, 2015, 20 (10) : 1277 - 1285
  • [43] Recent Advances in the Discovery of CB2 Selective Agonists
    Han, Sangdon
    Thatte, Jayant
    Jones, Robert M.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44, 2009, 44 : 227 - 246
  • [44] Identification and biochemical analyses of selective CB2 agonists
    Scott, Caitlin E.
    Tang, Yaliang
    Alt, Andrew
    Burford, Neil T.
    Gerritz, Samuel W.
    Ogawa, Lisa M.
    Zhang, Litao
    Kendall, Debra A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 854 : 1 - 8
  • [45] Design and synthesis of selective CB2 receptor antagonists
    Xiang, JN
    Atkinson, ST
    Wang, DY
    Lee, J
    Lee, JC
    Chritensen, SB
    Elliott, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U203 - U204
  • [46] 7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors
    Tanc, Muhammet
    Carta, Fabrizio
    Bozdag, Murat
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (15) : 4502 - 4510
  • [47] Investigation of the binding of isoform-selective inhibitors to prostaglandin endoperoxide synthases using fluorescence spectroscopy
    Lanzo, CA
    Beechem, JM
    Talley, J
    Marnett, LJ
    BIOCHEMISTRY, 1998, 37 (01) : 217 - 226
  • [48] Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors
    Reddy, Damodara N.
    Ballante, Flavio
    Chuang, Timothy
    Pirolli, Adele
    Marrocco, Biagina
    Marshall, Garland R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1613 - 1633
  • [49] Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy
    Wang, Guan
    Wu, Yongya
    Wu, Chengyong
    Shuai, Wen
    Jiang, Tingting
    Wang, Aoxue
    Bu, Faqian
    Sun, Qiu
    Ouyang, Liang
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (01) : 440 - 443
  • [50] Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy
    Guan Wang
    Yongya Wu
    Chengyong Wu
    Wen Shuai
    TingtingJiang
    Aoxue Wang
    Faqian Bu
    Qiu Sun
    Liang Ouyang
    Acta Pharmaceutica Sinica B, 2023, (01) : 440 - 443